Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on March 18, 2026
Mar. 18, 2026
Big Ed's Meds Under Investigation: Safe FDA-Approved ED Medications for Men
Indeterminate
GlobeNewswire
Mar. 18, 2026
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Indeterminate
GlobeNewswire
Mar. 18, 2026
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Indeterminate
GlobeNewswire
Mar. 18, 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 18, 2026
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Indeterminate
GlobeNewswire
Mar. 18, 2026
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
Indeterminate
GlobeNewswire
Mar. 18, 2026
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
Indeterminate
GlobeNewswire
Mar. 18, 2026
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Mar. 18, 2026
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Indeterminate
GlobeNewswire
Mar. 18, 2026
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Indeterminate
GlobeNewswire
Mar. 18, 2026
Red Boost Claims Evaluated: The Male Performance Powder Under Investigation
Indeterminate
GlobeNewswire
Mar. 18, 2026
Higher ACA premiums push more Marketplace consumers toward Bronze health plans
Indeterminate
GlobeNewswire
Mar. 18, 2026
Health Monitor Releases New Whitepaper on the Future of HCP and Pharma Communications in 2026
Indeterminate
GlobeNewswire